06 jun: Valuta: Euro taber momentum efter Draghi-meldinger
06 jun: ¨KORR: TKD: Kirk & Thorsen Invest køber aktier for 3,7 mio. kr.
06-06-2012 15:31:00

WSJ BLOG/Health: A.M. Vitals: J & J To Stop Selling Surgical Mesh

Relateret indhold
Relateret debat
19 apr - 
Sikke dog noget tømmermændssnak GW. Fordi du ikke kom m..
19 apr - 
Siger kloven i biotek
19 apr - 
Siger proffesoren i biotec.

(This story has been posted on The Wall Street Journal Online's Health Blog at http://blogs.wsj.com/health.)

By Amy Dockser Marcus

Here's what's happening in health news this morning:

J&J To Stop Selling Surgical Mesh (WSJ): Johnson & Johnson says it will stop selling its version of a surgical mesh product used to treat a painful pelvic condition in women.

Sex Bug Growing Resistant to Drugs, WHO Warns (AP): Gonorrhea, a sexually transmitted disease that infects millions, is growing resistant to drugs, raising worries among health officials that in a few years, it could become untreatable.

FDA Rejects Merck's Treatment for Bone Cancer (WSJ): The FDA rejected a new drug application for ridaforolimus, a bone cancer treatment, saying further trials are needed to assess the drug's effectiveness and safety.

Depressed? Treatment May Be A Phone Call Away (NPR Shots): Researchers at Northwestern University Feinberg School of Medicine found that people with major depression who received 18 weeks of talk therapy over the phone showed similar improvement to those who received the therapy in person, according to a study published in the Journal of the American Medical Association.

Exercise Benefits Black Girls Less Than Whites, Study Shows (LA Times): A study published in the Archives of Pediatrics and Adolescent Medicine compared white and black girls' physical activity and food intake and found that black adolescent girls don't appear to benefit as much from the effects of physical activity in preventing obesity as white peers.

-For continuously updated news from The Wall Street Journal, see WSJ.com at http://wsj.com.

(END) Dow Jones Newswires

June 06, 2012 09:31 ET (13:31 GMT)

Copyright (c) 2012 Dow Jones & Company, Inc.

Opret kommentar

Relateret debat

  • 1 uge
  • 1 måned
  • 1 År
Ingen indlæg

Fondsbørsmeddelelser

Nordfyns Bank Q1: Udlåns- og kundevækst sikrer godkendt start

28-04-2016 16:38:09
Trods en en mindre tilbagegang på både top- og bundlinjen har Nordfyns Bank fået en "tilfredsstillende" start på 2016. Det er særligt øget kundevækst og vækst i..

Novo: Semaglutid reducerer risikoen for hjerte-kar-tilfælde-NY2

28-04-2016 12:45:02
Novo Nordisk kan torsdag præsentere overbevisende studiedata med den nye langtidsvirkende GLP-1-analog Semaglutid, der har vist sig at reducere risikoen for hje..

Vestas vinder ordre på 76 MW til Sverige

28-04-2016 10:51:42
Den danske vindmøllevirksomhed Vestas har vundet en svensk ordre på 22 vindmøller af en samlet kapacitet på 76 MW.Ordren er afgivet af Fortum Generation AB, og ..

Mest læste nyheder

  • 24 timer
  • 48 timer
  • 1 uge
1
Novo: Semaglutid reducerer risikoen for hjerte-kar-tilfælde-NY2
2
Aktier/tendens: Jyske Bank stjæler fokus i sivende marked
3
Aktier/åbning: Jyske Bank bliver sendt ned efter regnskab
4
Vestas vinder ordre på 76 MW til Sverige
5
Mærsk/SHB: Kursmål sænkes til 9500 og anbefaling til "reducer"

Relaterede aktiekurser

Johnson & Johnson 112,31 -0,4% Fald i aktiekurs

Køb- og salgsanbefalinger

  • Trend
  • Pengemaskinen

Copyright Euroinvestor A/S 2016  Disclaimer Privatlivspolitik
Aktieinformation leveres af Interactive Data.
Data er forsinket 15-20 minutter iht. de enkelte børsers regler om videredistribution.
 
28. april 2016 21:51:07
(UTC+01:00) Brussels, Copenhagen, Madrid, Paris
Version: ReleaseBuild_20160421.1 - EUROWEB4 - 2016-04-28 21:51:07 - 2016-04-28 21:51:07 - 1 - Website: OKAY

Når du besøger Euroinvestor.dk accepterer du, at der anvendes cookies, som vi og vores samarbejdspartnere benytter til funktionalitet, statistik og markedsføring. Læs mere om cookies på Euroinvestor.dk her

x